Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy.
Saved in:
| Title: | Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy. |
|---|---|
| Authors: | Bolli R; Department of Medicine, University of Louisville, Louisville, KY. Electronic address: rbolli@louisville.edu., Tang XL; Department of Medicine, University of Louisville, Louisville, KY., Hare JM; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL., Mitrani RD; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL., Perin EC; Texas Heart Institute, CHI St. Luke's Health, Houston, TX., Lima JA; Department of Medicine, Johns Hopkins University, Baltimore, MD., Hurwitz BE; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL., Kalra D; Department of Medicine, University of Louisville, Louisville, KY., Singh G; Department of Medicine, University of Louisville, Louisville, KY., Saltzman RG; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL., Caceres LV; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL., Nettina A; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL., Lee YS; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL., Bacallao K; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL., Grant E; Biostatistics & Clinical Data Management, DP Clinical, Rockville, MD., Khan A; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL. |
| Source: | American heart journal [Am Heart J] 2026 Apr; Vol. 294, pp. 107328. Date of Electronic Publication: 2025 Dec 13. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41397478 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bolli+R%22">Bolli R</searchLink>; Department of Medicine, University of Louisville, Louisville, KY. Electronic address: rbolli@louisville.edu.<br /><searchLink fieldCode="AU" term="%22Tang+XL%22">Tang XL</searchLink>; Department of Medicine, University of Louisville, Louisville, KY.<br /><searchLink fieldCode="AU" term="%22Hare+JM%22">Hare JM</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Mitrani+RD%22">Mitrani RD</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Perin+EC%22">Perin EC</searchLink>; Texas Heart Institute, CHI St. Luke's Health, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Lima+JA%22">Lima JA</searchLink>; Department of Medicine, Johns Hopkins University, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Hurwitz+BE%22">Hurwitz BE</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Kalra+D%22">Kalra D</searchLink>; Department of Medicine, University of Louisville, Louisville, KY.<br /><searchLink fieldCode="AU" term="%22Singh+G%22">Singh G</searchLink>; Department of Medicine, University of Louisville, Louisville, KY.<br /><searchLink fieldCode="AU" term="%22Saltzman+RG%22">Saltzman RG</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Caceres+LV%22">Caceres LV</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Nettina+A%22">Nettina A</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Lee+YS%22">Lee YS</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Bacallao+K%22">Bacallao K</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Grant+E%22">Grant E</searchLink>; Biostatistics & Clinical Data Management, DP Clinical, Rockville, MD.<br /><searchLink fieldCode="AU" term="%22Khan+A%22">Khan A</searchLink>; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370465%22">American heart journal</searchLink> [Am Heart J] 2026 Apr; Vol. 294, pp. 107328. <i>Date of Electronic Publication: </i>2025 Dec 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial Protocol – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370465 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6744 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200028703%22">00028703 </searchLink><i>NLM ISO Abbreviation: </i>Am Heart J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41397478 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ahj.2025.107328 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 107328 Titles: – TitleFull: Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bolli R – PersonEntity: Name: NameFull: Tang XL – PersonEntity: Name: NameFull: Hare JM – PersonEntity: Name: NameFull: Mitrani RD – PersonEntity: Name: NameFull: Perin EC – PersonEntity: Name: NameFull: Lima JA – PersonEntity: Name: NameFull: Hurwitz BE – PersonEntity: Name: NameFull: Kalra D – PersonEntity: Name: NameFull: Singh G – PersonEntity: Name: NameFull: Saltzman RG – PersonEntity: Name: NameFull: Caceres LV – PersonEntity: Name: NameFull: Nettina A – PersonEntity: Name: NameFull: Lee YS – PersonEntity: Name: NameFull: Bacallao K – PersonEntity: Name: NameFull: Grant E – PersonEntity: Name: NameFull: Khan A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1097-6744 Numbering: – Type: volume Value: 294 Titles: – TitleFull: American heart journal Type: main |
| ResultId | 1 |
